Abstract
We propose a new filter based feature selection algorithm for classification based on DNA microarray gene expression data. It utilizes null space of covariance matrix for feature selection. The algorithm can perform bulk reduction of features (genes) while maintaining the quality information in the reduced subset of features for discriminative purpose. Thus, it can be used as a pre-processing step for other feature selection algorithms. The algorithm does not assume statistical independency among the features. The algorithm shows promising classification accuracy when compared with other existing techniques on several DNA microarray gene expression datasets.
Keywords: Cancer classification, covariance matrix, DNA microarray gene expression data, feature or gene selection, Filter based method, null space, algorithm, Random Forest (RF), support vector machine (SVM), acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML).
Current Bioinformatics
Title:A Filter Based Feature Selection Algorithm Using Null Space of Covariance Matrix for DNA Microarray Gene Expression Data
Volume: 7 Issue: 3
Author(s): Alok Sharma, Seiya Imoto and Satoru Miyano
Affiliation:
Keywords: Cancer classification, covariance matrix, DNA microarray gene expression data, feature or gene selection, Filter based method, null space, algorithm, Random Forest (RF), support vector machine (SVM), acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML).
Abstract: We propose a new filter based feature selection algorithm for classification based on DNA microarray gene expression data. It utilizes null space of covariance matrix for feature selection. The algorithm can perform bulk reduction of features (genes) while maintaining the quality information in the reduced subset of features for discriminative purpose. Thus, it can be used as a pre-processing step for other feature selection algorithms. The algorithm does not assume statistical independency among the features. The algorithm shows promising classification accuracy when compared with other existing techniques on several DNA microarray gene expression datasets.
Export Options
About this article
Cite this article as:
Sharma Alok, Imoto Seiya and Miyano Satoru, A Filter Based Feature Selection Algorithm Using Null Space of Covariance Matrix for DNA Microarray Gene Expression Data, Current Bioinformatics 2012; 7 (3) . https://dx.doi.org/10.2174/157489312802460802
DOI https://dx.doi.org/10.2174/157489312802460802 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Repurposing Screen Identifies Novel Classes of Drugs with Anticancer Activity in Mantle Cell Lymphoma
Combinatorial Chemistry & High Throughput Screening The Pharmacological Treatment of Cachexia
Current Drug Targets HtrA Serine Proteases as Potential Therapeutic Targets in Cancer
Current Cancer Drug Targets Ultrasound Characteristics in Complicated Ovarian Cysts
Current Women`s Health Reviews Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics
Current Drug Metabolism Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Towards Human on a Chip: Recent Progress and Future Perspective
Micro and Nanosystems Nanoparticles Mediated Target-specific Drug Delivery in Prostate Cancer: An In-depth Review
Current Medicinal Chemistry Anti-cancer Immunotoxins, Challenges, and Approaches
Current Pharmaceutical Design Telomere Recombination and the ALT Pathway: A Therapeutic Perspective for Cancer
Current Pharmaceutical Design Ribonucleases and ImmunoRNases as Anticancer Drugs
Current Pharmaceutical Design Evasion of Ribonuclease Inhibitor as a Determinant of Ribonuclease Cytotoxicity
Current Pharmaceutical Biotechnology Ligand-Targeted Liposomal Therapies of Neuroblastoma
Current Medicinal Chemistry Progress in the Understanding of the Immune Microenvironment and Immunotherapy in Malignant Pleural Mesothelioma
Current Drug Targets Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy
Current Cancer Drug Targets Epidemiology and Pathology of Malignant Mesothelioma
Current Respiratory Medicine Reviews Immunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Fyn Kinase in Brain Diseases and Cancer: The Search for Inhibitors
Current Medicinal Chemistry TRAIL Gene Therapy: From Preclinical Development to Clinical Application
Current Gene Therapy Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design